North America Active Pharmaceutical Ingredients Market Overview
Base Year: 2023
Historical Years: 2018-2023
Forecast Years: 2024-2032
Market Growth Rate: 5.8% (2024-2032)
Market Size in 2023: USD 74.1 Billion
Market Forecast in 2032: USD 123.1 Billion
According to the latest report by IMARC Group, the North America active pharmaceutical ingredients market size reached US$ 74.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 123.1 Billion by 2032, exhibiting a growth rate (CAGR) of 5.8% during 2024-2032. The(API) market is experiencing growth in biologics, as pharmaceutical companies shift focus toward biologic drugs for treating complex diseases.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/north-america-active-pharmaceutical-ingredients-market/requestsample
North America Active Pharmaceutical Ingredients Industry Trends and Drivers:
1. Rise of CMOs and CDMOs
- Growth of contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs) for cost-effective production.
- Companies increasingly rely on outsourcing to streamline operations and reduce expenses.
2. Advances in Synthetic Biology and Gene-Based Therapies
- Increased use of synthetic biology and gene-based therapies driven by biotechnology advancements.
- Personalized medicine development fostered by demand for small-batch, custom APIs.
3. Expansion of Generic Drug Production
- Growth in API manufacturing for generic drugs due to patent expirations of major medications.
- Contributes to overall market expansion.
4. Focus on Environmental Sustainability
- Rising emphasis on green chemistry practices in API production.
- Growing awareness of environmental sustainability in the pharmaceutical sector.
5. Drivers of API Demand
- Chronic Disease Prevalence: Increase in chronic diseases like cancer, diabetes, and cardiovascular disorders boosts API demand for both generic and innovative medications.
- Aging Population: Older adults require more medication for age-related conditions, driving API market growth.
- Rising Healthcare Expenditures: Investment in advanced research and development supports high-quality API production, meeting growing therapeutic needs.
6. Biologics, Biosimilars, and Precision Medicine
- Shift toward biologics and biosimilars requiring highly specialized APIs.
- Increasing focus on precision medicine and targeted therapies fuels demand for customized and small-batch APIs.
7. Expansion of Pharmaceutical Manufacturing
- Growth of pharmaceutical manufacturing, particularly CMOs, supports API market expansion.
- Outsourcing API production becoming more common to improve cost-efficiency.
8. Regulatory Support and Generic Drug Market Growth
- Favorable regulatory frameworks, including support from the U.S. FDA, encourage new drug development and approval.
- Rise in generic drug production, driven by patent expirations, increases API demand as manufacturers meet consumer demand for cost-effective alternatives.
North America Active Pharmaceutical Ingredients Industry Segmentation:
The report has segmented the market into the following categories:
Market by Drug Type
- Innovative Active Pharmaceutical Ingredients
- Generic Active Pharmaceutical Ingredients
Market by Manufacturer Type
- Captive Manufacturers
- Merchant API Manufacturers
- Innovative Merchant API Manufacturers
- Generic Merchant API Manufacturers
Market by Synthesis Type
- Synthetic Active Pharmaceutical Ingredients
- Innovative Synthetic APIs
- Generic Synthetic APIs
- Biotech Active Pharmaceutical Ingredients
- Market by Drug Type
- Innovative Biotech APIs
- Biosimilars
- Market by Product Type
- Monoclonal Antibodies
- Vaccines
- Cytokines
- Others
- Market by Expression System Type
- Mammalian Expression System
- Microbial Expression System
- Yeast Expression System
- Others
Market by Therapeutic Application
- Oncology
- Cardiovascular and Respiratory
- Diabetes
- Central Nervous System Disorders
- Neurological Disorders
- Others
Key Regions Analyzed
- United States
- Canada
- Mexico
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Ask Our Expert & Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=1521&flag=C
Key highlights of the Report:
- Market Performance (2018-2023)
- Market Outlook (2024-2032)
- COVID-19 Impact on the Market
- Porter’s Five Forces Analysis
- Strategic Recommendations
- Historical, Current and Future Market Trends
- Market Drivers and Success Factors
- SWOT Analysis
- Structure of the Market
- Value Chain Analysis
- Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145